August 30th 2022
Paris, August 30, 2022 – 6:00 pm CEST
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, announced today that various members of its management team will participate in the following investor and scientific conferences during the second half of 2022:
Investor Conferences
September 12-14, 2022 (New York, USA and virtual event)
Investor forum organized by the American investment bank H.C. Wainwright & Co.
To follow the presentation, click here.
September 29, 2022 (New York, USA)
Investor forum organized by the American investment bank Ladenburg Thalmann.
For more information, click here.
October 4, 2022 (virtual event)
Investor forum organized by Portzamparc, an investment bank specialized in the French small and mid-cap segment.
October 17 and 18, 2022 (Paris, France)
Investor forum dedicated to European small and mid-caps
Scientific Conferences
September 6-8, 2022 (Trieste, Italy)
International scientific conference on heart failure, dedicated this year to innovations and new treatment strategies in heart failure.
For more information, click here.
October 5-8, 2022 (Milan, Italy)
Scientific conference organized by the European Association of Cardio-Thoracic Surgery.
For more information, click here.
October 19-21, 2022 (Paris, France)
National conference on cardiac surgery organized by the Heart Institute of the Pitié Salpêtrière Hospital.
For more information, click here.
November 17-19, 2022 (Berlin, Germany)
Scientific conference of the European Association of Cardio-Thoracic Surgery dedicated to mechanical circulatory support.
For more information, click here.